Clinical Trails of Photoelectrochemical Immunosensor for Early Diagnosis of Acute Myocardial Infarction

Not Applicable

• Conditions: Acute Myocardial Infarction
• Interventions: Device: Graphene quantum dots combined with Si nanowire photoelectrochemical immunosensor

• Registration Number: NCT04390490
• Lead Sponsor: Bin He

Brief Summary

The aim of this prospective randomized controlled clinical trial will evaluate the sensitivity, precision and effectiveness of photoelectrochemical immunosensor for early diagosis of acute myocardial infarction.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2020-05-09
• Study First Submitted QC: 2020-05-13
• Study First Posted: 2020-05-15
• Status Verified: 2020-08
• Last Update Submitted: 2020-08-12
• Last Update Posted: 2020-08-17
• Study Start: 2020-10-01
• Primary Completion: 2022-09-30
• Study Completion: 2023-12-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Age > 18 years
• Symptoms of chest pain

Exclusion Criteria

• Patients who will undergo immediate PCI Pregnant
• Lactating women
• Patients with mental disorders
• Patients are using other experimental drugs; Refusal to provide informed.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Photoelectrochemical immunosensor	Graphene quantum dots combined with Si nanowire photoelectrochemical immunosensor	Photoelectrochemical immunosensor will be used for dectecting the concentration of cardiac troponin I as test group.

Primary Outcome Measures

Name	Time	Method
Effectiveness of photoelectrochemical immunosensor	28 days	Sensitivity，precision and cost of the photoeletrochemical immunosensor

Trial Locations

Locations (1)

Ethics Committee of Xinhua Hospital; 🇨🇳 Shanghai, Shanghai, China